Patients undergoing dialysis are at risk for low blood pressure, fluid buildup or infections and problems can be overlooked if nurses don’t have enough time to devote to their patients and to transitions between patients.
The company, which wants to disrupt the dialysis service model, envisions its dialysis device eventually being used in patient homes.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Home dialysis is not regarded as a threat to the viability of dialysis centers.
Some ambulance operators say they feel caught between wanting to help sick people and obeying the rules that determine whether Medicare will pay them.
Opsonix, a Cambridge spinout based on technology from Harvard University, just raised $8 million in a Series A for its device that filters a variety of pathogens from the bloodstream - preventing diseases like sepsis from becoming full-blown.
DaVita HealthCare Partners has acquired dialysis operator Renal Venture for $415 million.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
More than 100,000 people in the United States are waiting for a kidney transplant. A Nobel Prize winning economist is looking at ways to make the process easier for everyone involved.
Outset Medical has developed an all-in-one dialysis machine that could reduce providers' overhead - changing the service model and cutting staff.
Outset Medical just raised $60 million - and possibly more - to build out its at-home dialysis machine for patients with kidney failure.
Scientists in Wales have potentially uncovered a new way to quickly identify bacterial infections using clues given off by a patient’s so-called immune fingerprint. Working with chronic kidney disease patients who acquired infections during dialysis, researchers at Cardiff University’s School of Medicine in the UK showed proof-of-concept that a person’s “immune fingerprint” reflected which organism […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Medtronic (MDT) has signed a deal with Apollo Hospitals Enterprise to develop a new hemodialysis system to help patients with end-stage renal disease (ESRD). The medical devices company will cover the technology, Apollo the “clinical insight.” This collaboration marks the first instance Medtronic will use a full India-based R&D team. Medtronic said it will develop […]
DARPA awarded Battelle, NxStage Medical and Aethlon Medical a contract to develop a device to treat sepsis, which can arise from as much as 10 percent of combat wounds, for military use, according to a Battelle press release. The contract, which could lead to $22.8 million dollars and four years worth of work for the […]
A Duke University spinoff has reached a milestone in tissue engineering as it transplanted the first bioengineered blood vessel into the arm of a patient with end-stage kidney disease. In its first U.S. clinical trial, Humacyte is testing the safety and effectiveness of the blood vessel, which is intended to be an off-the-shelf product that’s […]
For the more than 870,000 patients in the U.S. being treated for end-stage renal disease, hemodialysis treatments become part of a daily or multiple-times-a-week routine. In order to perform dialysis, clinicians must create long-term, high-flow access to a patient’s blood vessels. But current access options, like arteriovenous fistulas, arteriovenous grafts and central venous catheters, can […]